| Tag | Content |
|---|
EnhancerAtlas ID | HS120-03198 |
Organism | Homo sapiens |
Tissue/cell | LNCaP-abl |
Coordinate | chr19:11009660-11010390 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Klf1 | MA0493.1 | chr19:11010306-11010317 | TGGGTGTGGCC | - | 6.62 | | TFAP2A | MA0003.3 | chr19:11009971-11009982 | CGCCTCAGGCA | + | 6.62 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_23673 | chr19:11008924-11010460 | Colon_Crypt_1 | | SE_24532 | chr19:11008947-11010425 | Colon_Crypt_2 | | SE_30825 | chr19:11008999-11010458 | Fetal_Muscle | | SE_48197 | chr19:11008793-11011250 | Psoas_Muscle | | SE_51520 | chr19:11008746-11011610 | Skeletal_Muscle | | SE_68858 | chr19:11008941-11010261 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I010898 | chr19 | 11009109 | 11010781 |
|
Enhancer Sequence | CAGAGGCTCG GGAGTCTCCT GAACAAAGAG AGGAACACGG CTTAGCTTGT TTTTTTTTTT 60
TTTTTTTTTG GTTTGTCAGT ATTTCCCAGG TGTCTTCTGT GTGCCAGGGA CTAACTTGGG 120
GATAAAGCTG TGACTTTGAG AAGCTGCCGG CTCCGCGGGC TTTAGCAGCT GCTGCTGTGA 180
TGAAGCGATC CACTTGCCCT CAGCCCCGGC ATCTTTGGCC CAAGCCCAGC CCTAGCCCTG 240
GCTGGGCACA GCCAGGCTTC ACTTGGCCAC AGGTCCTGTA GTTGCCTGCC TGGCGCCAGG 300
TCAGAGAGGG ACGCCTCAGG CAACATCGGG TTGCCAGGCT GCTTGGTAAA CAGGCCTCCC 360
TGGGCCCACT TGCTGTCGCC CAGGTGTGGC TAACAGATCG ACAGTATCTC CTGCCCCAGG 420
ACGGGTATGA GTGTGGGCAC CATGCCAAGG TTGGATGTCC CTTCCTGGGA CCCACCCACA 480
GCTGGGAGCA CTTTATCTTG GGCCTCTGTG GGTGTAGTGA GGCTGTGAGT CTGGGGCAGT 540
GGCCTGCTGA CACCCTCCTG GCAGGGCTCA GGAGGTTCCT CCATGCCCTG CCCTCAGGAG 600
GGCGGCACCT GGCTCCTGGG GTGGGAGAGA GTCTGGCAGG ACTGGCTGGG TGTGGCCGGG 660
GAGCTGCCCT TCAGGTCTCA TATCTGTAGG CCCTCATACC TGGACTCGTC AGTTAGGAAC 720
AGTTTTCTTT 730
|
